Medial Arterial Calcification: An Overlooked Player in Peripheral Arterial Disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 8, 2016, Pages 1475-1482

  Ho, Chin Yee ^a   Shanahan, Catherine M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

aging; calcification; DNA damage; neuropathy; nuclear lamina

Indexed keywords

ARTERY CALCIFICATION; ATHEROSCLEROSIS; BONE DEVELOPMENT; CARDIOVASCULAR RISK; CELL AGING; CHONDROGENESIS; DISEASE COURSE; DNA DAMAGE; HISTOPATHOLOGY; HUMAN; NEUROPATHY; NONHUMAN; NUCLEAR LAMINA; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PREMATURE AGING; PRIORITY JOURNAL; REVIEW; ANIMAL; ARTERY; DIABETIC NEUROPATHIES; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MONCKEBERG MEDIAL CALCIFIC SCLEROSIS; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; RISK FACTOR; SIGNAL TRANSDUCTION;

ANIMALS; ARTERIES; CELL AGING; CHONDROGENESIS; DIABETIC NEUROPATHIES; DNA DAMAGE; GENE EXPRESSION REGULATION; HUMANS; MONCKEBERG MEDIAL CALCIFIC SCLEROSIS; NUCLEAR LAMINA; OSTEOGENESIS; OXIDATIVE STRESS; PERIPHERAL ARTERIAL DISEASE; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 84975117214     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.116.306717     Document Type: Review

References (75)

1. Lehto S, Niskanen L, Suhonen M, Rönnemaa T, Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 1996;16:978-983
2. Rocha-Singh KJ, Zeller T, Jaff MR. Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv. 2014;83:E212-E220. doi: 10. 1002/ccd. 25387
3. O'Neill WC, Han KH, Schneider TM, Hennigar RA. Prevalence of nonatheromatous lesions in peripheral arterial disease. Arterioscler Thromb Vasc Biol. 2015;35:439-447. doi: 10. 1161/ATVBAHA. 114. 304764
4. Guzman RJ, Bian A, Shintani A, Stein CM. Association of foot ulcer with tibial artery calcification is independent of peripheral occlusive disease in type 2 diabetes. Diabetes Res Clin Pract. 2013;99:281-286. doi: 10. 1016/j. diabres. 2012. 12. 022
5. Guzman RJ, Brinkley DM, Schumacher PM, Donahue RM, Beavers H, Qin X. Tibial artery calcification as a marker of amputation risk in patients with peripheral arterial disease. J Am Coll Cardiol. 2008;51:1967-1974. doi: 10. 1016/j. jacc. 2007. 12. 058
6. Wukich DK, Shen W, Raspovic KM, Suder NC, Baril DT, Avgerinos E. Noninvasive arterial testing in patients with diabetes: a guide for foot and ankle surgeons. Foot Ankle Int. 2015;36:1391-1399. doi: 10. 1177/1071100715593888
7. Otsuka F, Nakano M, Sakakura K, Ladich E, Kolodgie FD, Virmani R. Unique demands of the femoral anatomy and pathology and the need for unique interventions. J Cardiovasc Surg (Torino). 2013;54:191-210
8. Kalra SS, Shanahan CM. Vascular calcification and hypertension: cause and effect. Ann Med. 2012;44(suppl 1):S85-S92. doi: 10. 3109/07853890. 2012. 660498
9. Hutcheson JD, Maldonado N, Aikawa E. Small entities with large impact: microcalcifications and atherosclerotic plaque vulnerability. Curr Opin Lipidol. 2014;25:327-332. doi: 10. 1097/MOL. 0000000000000105
10. Lanzer P, Boehm M, Sorribas V, Thiriet M, Janzen J, Zeller T, St Hilaire C, Shanahan C. Medial vascular calcification revisited: review and perspectives. Eur Heart J. 2014;35:1515-1525. doi: 10. 1093/eurheartj/ehu163
11. Husmann M, Jacomella V, Thalhammer C, Amann-Vesti BR. Markers of arterial stiffness in peripheral arterial disease. Vasa. 2015;44:341-348. doi: 10. 1024/0301-1526/a000452
12. Soor GS, Vukin I, Leong SW, Oreopoulos G, Butany J. Peripheral vascular disease: who gets it and why? A histomorphological analysis of 261 arterial segments from 58 cases. Pathology. 2008;40:385-391. doi: 10. 1080/00313020802036764
13. Han KH, Hennigar RA, O'Neill WC. The association of bone and osteoclasts with vascular calcification. Vasc Med. 2015;20:527-533. doi: 10. 1177/1358863X15597076
14. Lachman AS, Spray TL, Kerwin DM, Shugoll GI, Roberts WC. Medial calcinosis of Mönckeberg. A review of the problem and a description of a patient with involvement of peripheral, visceral and coronary arteries. Am J Med. 1977;63:615-622
15. Qiao JH, Doherty TM, Fishbein MC, Salusky IB, Luthringer DL, Fitzpatrick LA, Shah PK, Rajavashisth TB. Calcification of the coronary arteries in the absence of atherosclerotic plaque. Mayo Clinic proceedings. 2005;80:807-809
16. Qiao JH, Mertens RB, Fishbein MC, Geller SA. Cartilaginous metaplasia in calcified diabetic peripheral vascular disease: morphologic evidence of enchondral ossification. Hum Pathol. 2003;34:402-407. doi: 10. 1053/ hupa. 2003. 72
17. Top C, Cankir Z, Silit E, Yildirim S, Danaci M. Mönckeberg's sclerosis: an unusual presentation-A case report. Angiology. 2002;53:483-486
18. Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME. Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation. 1999;100:2168-2176
19. Brandenburg VM, Sinha S, Specht P, Ketteler M. Calcific uraemic arteriolopathy: a rare disease with a potentially high impact on chronic kidney disease-mineral and bone disorder. Pediatr Nephrol. 2014;29:2289-2298. doi: 10. 1007/s00467-013-2746-7
20. Shroff RC, McNair R, Figg N, Skepper JN, Schurgers L, Gupta A, Hiorns M, Donald AE, Deanfield J, Rees L, Shanahan CM. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation. 2008;118:1748-1757. doi: 10. 1161/ CIRCULATIONAHA. 108. 783738
21. Schurgers LJ, Joosen IA, Laufer EM, et al. Vitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype. PLoS One. 2012;7:e43229. doi: 10. 1371/journal. pone. 0043229
22. Kapustin AN, Shanahan CM. Calcium regulation of vascular smooth muscle cell-derived matrix vesicles. Trends Cardiovasc Med. 2012;22:133-137. doi: 10. 1016/j. tcm. 2012. 07. 009
23. Kapustin AN, Chatrou ML, Drozdov I, et al. Vascular smooth muscle cell calcification is mediated by regulated exosome secretion. Circ Res. 2015;116:1312-1323. doi: 10. 1161/CIRCRESAHA. 116. 305012
24. Tyson KL, Reynolds JL, McNair R, Zhang Q, Weissberg PL, Shanahan CM. Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol. 2003;23:489-494. doi: 10. 1161/01. ATV. 0000059406. 92165. 31
25. Rutsch F, Nitschke Y, Terkeltaub R. Genetics in arterial calcification: pieces of a puzzle and cogs in a wheel. Circ Res. 2011;109:578-592. doi: 10. 1161/CIRCRESAHA. 111. 247965
26. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, Proudfoot D, Jahnen-Dechent W, Weissberg PL, Shanahan CM. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol. 2004;15:2857-2867. doi: 10. 1097/01. ASN. 0000141960. 01035. 28
27. Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res. 2011;109:697-711. doi: 10. 1161/CIRCRESAHA. 110. 234914
28. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 1997;386:78-81. doi: 10. 1038/386078a0
29. Nitschke Y, Rutsch F. Genetics in arterial calcification: lessons learned from rare diseases. Trends Cardiovasc Med. 2012;22:145-149. doi: 10. 1016/j. tcm. 2012. 07. 011
30. St Hilaire C, Ziegler SG, Markello TC, et al. NT5E mutations and arterial calcifications. N Engl J Med. 2011;364:432-442. doi: 10. 1056/ NEJMoa0912923
31. Speer MY, Li X, Hiremath PG, Giachelli CM. Runx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis. J Cell Biochem. 2010;110:935-947. doi: 10. 1002/jcb. 22607
32. Tanaka T, Sato H, Doi H, Yoshida CA, Shimizu T, Matsui H, Yamazaki M, Akiyama H, Kawai-Kowase K, Iso T, Komori T, Arai M, Kurabayashi M. Runx2 represses myocardin-mediated differentiation and facilitates osteogenic conversion of vascular smooth muscle cells. Mol Cell Biol. 2008;28:1147-1160. doi: 10. 1128/MCB. 01771-07
33. Liu Y, Drozdov I, Shroff R, Beltran LE, Shanahan CM. Prelamin A accelerates vascular calcification via activation of the DNA damage response and senescence-associated secretory phenotype in vascular smooth muscle cells. Circ Res. 2013;112:e99-109. doi: 10. 1161/ CIRCRESAHA. 111. 300543
34. Ragnauth CD, Warren DT, Liu Y, McNair R, Tajsic T, Figg N, Shroff R, Skepper J, Shanahan CM. Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging. Circulation. 2010;121:2200-2210. doi: 10. 1161/CIRCULATIONAHA. 109. 902056
35. Minamino T, Komuro I. Vascular cell senescence: contribution to atherosclerosis. Circ Res. 2007;100:15-26. doi: 10. 1161/01. RES. 0000256837. 40544. 4a
36. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res. 1965;37:614-636
37. Matthews C, Gorenne I, Scott S, Figg N, Kirkpatrick P, Ritchie A, Goddard M, Bennett M. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ Res. 2006;99:156-164. doi: 10. 1161/01. RES. 0000233315. 38086. bc
38. Warren DT, Shanahan CM. Defective DNA-damage repair induced by nuclear lamina dysfunction is a key mediator of smooth muscle cell aging. Biochem Soc Trans. 2011;39:1780-1785. doi: 10. 1042/BST20110703
39. Signorelli SS, Fiore V, Malaponte G. Inflammation and peripheral arterial disease: the value of circulating biomarkers (Review). Int J Mol Med. 2014;33:777-783. doi: 10. 3892/ijmm. 2014. 1657
40. Bailey-Downs LC, Tucsek Z, Toth P, Sosnowska D, Gautam T, Sonntag WE, Csiszar A, Ungvari Z. Aging exacerbates obesity-induced oxidative stress and inflammation in perivascular adipose tissue in mice: a paracrine mechanism contributing to vascular redox dysregulation and inflammation. J Gerontol A Biol Sci Med Sci. 2013;68:780-792. doi: 10. 1093/ gerona/gls238
41. Bonomini F, Rodella LF, Rezzani R. Metabolic syndrome, aging and involvement of oxidative stress. Aging Dis. 2015;6:109-120. doi: 10. 14336/AD. 2014. 0305
42. Fyhrquist F, Saijonmaa O, Strandberg T. The roles of senescence and telomere shortening in cardiovascular disease. Nat Rev Cardiol. 2013;10:274-283. doi: 10. 1038/nrcardio. 2013. 30
43. Madamanchi NR, Runge MS. Mitochondrial dysfunction in atherosclerosis. Circ Res. 2007;100:460-473. doi: 10. 1161/01. RES. 0000258450. 44413. 96
44. Salpea KD, Humphries SE. Telomere length in atherosclerosis and diabetes. Atherosclerosis. 2010;209:35-38. doi: 10. 1016/j. atherosclerosis. 2009. 12. 021
45. Durik M, Kavousi M, van der Pluijm I, et al. Nucleotide excision DNA repair is associated with age-related vascular dysfunction. Circulation. 2012;126:468-478
46. Al-Aubaidy HA, Jelinek HF. 8-Hydroxy-2-deoxy-guanosine identifies oxidative DNA damage in a rural prediabetes cohort. Redox Rep. 2010;15:155-160. doi: 10. 1179/174329210X12650506623681
47. Aykanat B, Demircigil GC, Fidan K, Buyan N, Gulleroglu K, Baskin E, Bayrakci US, Sepici A, Buyukkaragoz B, Karakayali H, Haberal M, Burgaz S. Basal damage and oxidative DNA damage in children with chronic kidney disease measured by use of the comet assay. Mutat Res. 2011;725:22-28. doi: 10. 1016/j. mrgentox. 2011. 07. 005
48. Pereira S, Bourgeois P, Navarro C, Esteves-Vieira V, Cau P, De Sandre-Giovannoli A, Lévy N. HGPS and related premature aging disorders: from genomic identification to the first therapeutic approaches. Mech Ageing Dev. 2008;129:449-459. doi: 10. 1016/j. mad. 2008. 04. 003
49. Varga R, Eriksson M, Erdos MR, et al. Progressive vascular smooth muscle cell defects in a mouse model of hutchinson-gilford progeria syndrome. Proc Natl Acad Sci USA. 2006;103:3250-3255
50. Villa-Bellosta R, Rivera-Torres J, Osorio FG, Acín-Pérez R, Enriquez JA, López-Otín C, Andrés V. Defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of Hutchinson-Gilford progeria syndrome that is ameliorated on pyrophosphate treatment. Circulation. 2013;127:2442-2451. doi: 10. 1161/ CIRCULATIONAHA. 112. 000571
51. Butin-Israeli V, Adam SA, Goldman AE, Goldman RD. Nuclear lamin functions and disease. Trends Genet. 2012;28:464-471. doi: 10. 1016/j. tig. 2012. 06. 001
52. Scaffidi P, Misteli T. Lamin A-dependent nuclear defects in human aging. Science. 2006;312:1059-1063. doi: 10. 1126/science. 1127168
53. Shanahan CM. Mechanisms of vascular calcification in CKD-evidence for premature ageing? Nat Rev Nephrol. 2013;9:661-670. doi: 10. 1038/ nrneph. 2013. 176
54. Liu B, Wang J, Chan KM, et al. Genomic instability in laminopathy-based premature aging. Nat Med. 2005;11:780-785. doi: 10. 1038/nm1266
55. Afonso P, Auclair M, Boccara F, Vantyghem MC, Katlama C, Capeau J, Vigouroux C, Caron-Debarle M. LMNA mutations resulting in lipodystrophy and HIV protease inhibitors trigger vascular smooth muscle cell senescence and calcification: Role of ZMPSTE24 downregulation. Atherosclerosis. 2016;245:200-211. doi: 10. 1016/j. atherosclerosis. 2015. 12. 012
56. Edmonds ME, Morrison N, Laws JW, Watkins PJ. Medial arterial calcification and diabetic neuropathy. Br Med J (Clin Res Ed). 1982;284:928-930
57. Moon JS, Clark VM, Beabout JW, Swee RG, Dyck PJ. A controlled study of medial arterial calcification of legs: implications for diabetic polyneuropathy. Arch Neurol. 2011;68:1290-1294. doi: 10. 1001/archneurol. 2011. 211
58. Petrova NL, Shanahan CM. Neuropathy and the vascular-bone axis in diabetes: lessons from Charcot osteoarthropathy. Osteoporos Int. 2014;25:1197-1207. doi: 10. 1007/s00198-013-2511-6
59. Goebel FD, Füessl HS. Mönckeberg's sclerosis after sympathetic denervation in diabetic and non-diabetic subjects. Diabetologia. 1983;24:347-350
60. Springer J, Fischer A. Substance P-induced pulmonary vascular remodelling in precision cut lung slices. Eur Respir J. 2003;22:596-601
61. Chen MJ, Chiang LY, Lai YL. Reactive oxygen species and substance P in monocrotaline-induced pulmonary hypertension. Toxicol Appl Pharmacol. 2001;171:165-173. doi: 10. 1006/taap. 2000. 9117
62. Zukowska-Grojec Z, Pruszczyk P, Colton C, Yao J, Shen GH, Myers AK, Wahlestedt C. Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells. Peptides. 1993;14:263-268
63. Shigeri Y, Fujimoto M. Neuropeptide Y stimulates DNA synthesis in vascular smooth muscle cells. Neurosci Lett. 1993;149:19-22
64. Kähler CM, Schratzberger P, Wiedermann CJ. Response of vascular smooth muscle cells to the neuropeptide secretoneurin. A functional role for migration and proliferation in vitro. Arterioscler Thromb Vasc Biol. 1997;17:2029-2035
65. Markakis K, Bowling FL, Boulton AJ. The diabetic foot in 2015: an overview. Diab/Metab Res Rev. 2015;32:169-178. doi: 10. 1002/dmrr. 2740
66. Sharma A, Scammell BE, Fairbairn KJ, Seagrave MJ, Game FL, Jeffcoate WJ. Prevalence of calcification in the pedal arteries in diabetes complicated by foot disease. Diabetes Care. 2010;33:e66. doi: 10. 2337/dc09-2185
67. Demer LL, Tintut Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation. 2008;117:2938-2948. doi: 10. 1161/ CIRCULATIONAHA. 107. 743161
68. Bennett BJ, Scatena M, Kirk EA, Rattazzi M, Varon RM, Averill M, Schwartz SM, Giachelli CM, Rosenfeld ME. Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/-mice. Arterioscler Thromb Vasc Biol. 2006;26:2117-2124. doi: 10. 1161/01. ATV. 0000236428. 91125. e6
69. Deuell KA, Callegari A, Giachelli CM, Rosenfeld ME, Scatena M. RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-α. J Vasc Res. 2012;49:510-521. doi: 10. 1159/000341216
70. Jeffcoate W. Vascular calcification and osteolysis in diabetic neuropathyis RANK-L the missing link? Diabetologia. 2004;47:1488-1492. doi: 10. 1007/s00125-004-1477-5
71. Pittenger G, Vinik A. Nerve growth factor and diabetic neuropathy. Exp Diabesity Res. 2003;4:271-285. doi: 10. 1155/EDR. 2003. 271
72. Connat JL, Busseuil D, Gambert S, Ody M, Tébaldini M, Gamboni S, Faivre B, Quiquerez AL, Millet M, Michaut P, Rochette L. Modification of the rat aortic wall during ageing; possible relation with decrease of peptidergic innervation. Anat Embryol (Berl). 2001;204:455-468
73. Connat JL, Schnüriger V, Zanone R, Schaeffer C, Gaillard M, Faivre B, Rochette L. The neuropeptide calcitonin gene-related peptide differently modulates proliferation and differentiation of smooth muscle cells in culture depending on the cell type. Regul Pept. 2001;101: 169-178
74. Joshi NV, Vesey AT, Williams MC, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet. 2014;383:705-713. doi: 10. 1016/S0140-6736(13)61754-7
75. Dweck MR, Jenkins WS, Vesey AT, et al. 18F-sodium fluoride uptake is a marker of active calcification and disease progression in patients with aortic stenosis. Circ Cardiovasc Imaging. 2014;7:371-378. doi: 10. 1161/ CIRCIMAGING. 113. 001508